Abstract
Degradation of membrane-bound sphingomyelin to phosphorylcholine and ceramide is catalyzed by the water-soluble lysosomal acid sphingomyelinase (A-SMase). The presence of sphingolipid activator proteins (Saps: saposins A-D; GM2 activator) is not essential to mediate this reaction at the water-lipid interface in vivo. A hypothesis based on amino acid sequence alignments suggests that the enzyme possesses an N-terminal saposin-homologous domain, which may facilitate the enzymatic reaction at the interface. We mutated one homologous and three conserved amino acid residues of this domain and studied the activity of the variant enzymes using different sphingomyelin degradation assays. A variant with an exchange of a conserved amino acid residue, Pro153Ala, still exhibited enzyme activity of approximately 52% of normal in a detergent-containing micellar assay, but only 13% of normal in a detergent-free liposomal assay system, which suggests that the Sap-homologous domain fulfills membrane-disturbing functions. Addition of saposin C to the liposomal assay mixtures increased the Pro153Ala variant sphingomyelinase activity to 46% of normal, indicating that the variant saposin-like domain can be substituted by the presence of the sphingolipid activator protein. On the other hand, the addition of saposin C did not result in complete restoration of the variant activity. Thus, the Sap-like domain may also have another role, e.g., to stabilize the fold of acid sphingomyelinase, which cannot be compensated by the presence of saposin C or a detergent. Such an essential second function of the saposin-like domain as an integral part of acid sphingomyelinase is confirmed by our observation that the Lys118Glu, Cys120Ser and Cys131Ser variants were almost completely devoid of activity in the detergent-containing micellar assay system as well as in the liposomal assay system in the presence of saposin C.
References
Ahn, V.E., Faull, K.F., Whitelegge, J.P., Fluhart, A.L., and Prive, G.G. (2003). Crystal structure of saposin B reveals a dimeric shell for lipid binding. Proc. Natl. Acad. Sci. USA100, 38–43.10.1073/pnas.0136947100Search in Google Scholar
Bartelsen, O. (1999). Baculovirus-Expression der menschlichen sauren Sphingomyelinase. PhD Thesis (Bonn, Germany: University of Bonn).Search in Google Scholar
Bradova, V., Smid, F., Ulrich-Bott, B., Roggendorf, W., Paton, B.C., and Harzer, K. (1993). Prosaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs. Multiple glycolipid elevations (including lactosylceramidosis), partial enzyme deficiencies and ultrastructure of the skin in this generalized sphingolipid storage disease. Hum. Genet.92, 143–152.10.1007/BF00219682Search in Google Scholar
Dewji, N.N., Wenger, D.A., and O'Brien, J.S. (1987). Nucleotide sequence of cloned cDNA for human sphingolipid activator protein 1 precursor. Proc. Natl. Acad. Sci. USA84, 8652–8656.10.1073/pnas.84.23.8652Search in Google Scholar
Fürst, W., and Sandhoff, K. (1992). Activator proteins and topology of lysosomal sphingolipid catabolism. Biochim. Biophys. Acta1126, 1–16.10.1016/0005-2760(92)90210-MSearch in Google Scholar
Ida, H., Rennert, O.M., Eto, Y., and Chan, W.Y. (1993). Cloning of a human acid sphingomyelinase cDNA with a new mutation that renders the enzyme inactive. J. Biochem.114, 15–20.10.1093/oxfordjournals.jbchem.a124131Search in Google Scholar
Ikonomov, O.C., Sbrissa, D., Mlak, K., Kanzaki, M., Pessin, J., and Shisheva, A. (2002). Functional dissection of lipid and protein kinase signals of PIKfyve reveals the role of PtdIns 3,5-P2 production for endomembrane integrity. J. Biol. Chem.277, 9206–9211.10.1074/jbc.M108750200Search in Google Scholar
Klingenstein, R. (2002). Sphingolipid-Aktivatorproteine: Expression in Pichia pastoris und Untersuchung ihrer Wechselwirkungen mit Modellmembranen. PhD Thesis (Bonn, Germany: University of Bonn).Search in Google Scholar
Lansmann, S., Schuette, C.G., Bartelsen, O., Hoernschemeyer, J., Linke, T., Weisgerber, J., and Sandhoff, K. (2003). Human acid sphingomyelinase. Assignment of the disulfide bond pattern. Eur. J. Biochem.270, 1076–1088.Search in Google Scholar
Linke, T., Wilkening, G., Lansmann, S., Moczall, H., Bartelsen, O., Weisgerber, J., and Sandhoff, K. (2001). Stimulation of acid sphingomyelinase activity by lysosomal lipids and sphingolipid activator proteins. Biol. Chem.382, 283–290.10.1515/BC.2001.035Search in Google Scholar
MacDonald, R.C., MacDonald, R.I., Menco, B.P., Takeshita, K., Subbarao, N.K., and Hu, L.R. (1991). Small-volume extrusion apparatus for preparation of large, unilamellar vesicles. Biochim. Biophys. Acta1061, 297–303.10.1016/0005-2736(91)90295-JSearch in Google Scholar
Möbius, W., van Donselaar, E., Ohno-Iwashita, Y., Shimada, Y., Heijnen, H.F., Slot, J.W., and Geuze, H.J. (2003). Recycling compartments and the internal vesicles of multivesicular bodies harbor most of the cholesterol found in the endocytic pathway. Traffic4, 222–231.10.1034/j.1600-0854.2003.00072.xSearch in Google Scholar PubMed
Paton, B.C., Schmid, B., Kustermann-Kuhn, B., Poulos, A., and Harzer, K. (1992). Additional biochemical findings in a patient and fetal sibling with a genetic defect in the sphingolipid activator protein (SAP) precursor, prosaposin. Evidence for a deficiency in SAP-1 and for a normal lysosomal neuraminidase. Biochem. J.285, 481–488.Search in Google Scholar
Ponting, C.P. (1994). Acid sphingomyelinase possesses a domain homologous to its activator proteins: saposins B and D. Protein Sci.3, 359–361.10.1002/pro.5560030219Search in Google Scholar PubMed PubMed Central
Quintern, L.E., and Sandhoff, K. (1991). Human acid sphingomyelinase from human urine. Methods Enzymol.197, 536–540.10.1016/0076-6879(91)97180-7Search in Google Scholar
Quintern, L.E., Weitz, G., Nehrkorn, H., Tager, J.M., Schram, A.W., and Sandhoff, K. (1987). Acid sphingomyelinase from human urine: purification and characterization. Biochim. Biophys. Acta922, 323–336.10.1016/0005-2760(87)90055-5Search in Google Scholar
Quintern, L.E., Schuchman, E.H., Levran, O., Suchi, M., Ferlinz, K., Reinke, H., Sandhoff, K., and Desnick, R.J. (1989). Isolation of cDNA clones encoding human acid sphingomyelinase: occurrence of alternatively processed transcripts. EMBO J.8, 2469–2473.10.1002/j.1460-2075.1989.tb08382.xSearch in Google Scholar
Sandhoff, K., and Kolter, T. (1996). Topology of glycosphingolipid degradation. Trends Cell Biol.6, 98–103.10.1016/0962-8924(96)80999-8Search in Google Scholar
Schissel, S.L., Keesler, G.A., Schuchman, E.H., Williams, K.J., and Tabas, I. (1998). The cellular trafficking and zinc dependence of secretory and lysosomal sphingomyelinase, two products of the acid sphingomyelinase gene. J. Biol. Chem.273, 18250–18259.10.1074/jbc.273.29.18250Search in Google Scholar
Schuchman, E.H., and Desnick, R.J. (2001). The Metabolic Basis of Inherited Disease (New York, USA: McGraw-Hill), pp. 2601–2623.Search in Google Scholar
Schuchman, E.H., Suchi, M., Takahashi, T., Sandhoff, K., and Desnick, R.J. (1991). Human acid sphingomyelinase. Isolation, nucleotide sequence and expression of the full-length and alternatively spliced cDNAs. J. Biol. Chem.266, 8531–8539.Search in Google Scholar
Wilkening, G., Linke, T., Uhlhorn-Dierks, G., and Sandhoff, K. (2000). Degradation of membrane-bound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP. J. Biol. Chem.275, 35814–35819.10.1074/jbc.M006568200Search in Google Scholar
Wu, Y.Y., Lockyer, J.M., Sugiyama, E., Pavlova, N.V., Li, Y.T., and Li, S.C. (1994). Expression and specificity of human GM2 activator protein. J. Biol. Chem.269, 16276–16283.10.1016/S0021-9258(17)34004-8Search in Google Scholar
©2004 by Walter de Gruyter Berlin New York
